| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 2,294 | 3,000 | 0.00% | ||
| 2 | ASTERIAS BIOTHERAPEUTICS INC COM SER A | 1,875 | 9,000 | 0.00% | ||
| 3 | CELLADON CORP | 75,000 | 95,000 | 0.01% | ||
| 4 | Theravance Biopharma Inc | 11,428 | 149,000 | 0.02% | ||
| 5 | GERON CORP | 45,000 | 193,000 | 0.03% | ||
| 6 | CERUS CORP | 46,520 | 241,000 | 0.03% | ||
| 7 | WRIGHT MEDICAL GROUP NV | 10,000 | 263,000 | 0.04% | ||
| 8 | PAREXEL INTERNATIONAL CORPORATION | 5,000 | 322,000 | 0.04% | ||
| 9 | PUMA BIOTECHNOLOGY | 3,000 | 350,000 | 0.05% | ||
| 10 | ENDOCHOICE HLDGS INC | 22,056 | 361,000 | 0.05% | ||
| 11 | EXELIXIS INC | 100,000 | 376,000 | 0.05% | ||
| 12 | RELYPSA INC | 15,000 | 496,000 | 0.07% | ||
| 13 | ENTELLUS MED INC | 20,000 | 517,000 | 0.07% | ||
| 14 | CARDIOVASCULAR SYS INC DEL COM | 20,000 | 529,000 | 0.07% | ||
| 15 | TANDEM DIABETES CARE INC COM | 50,000 | 542,000 | 0.08% | ||
| 16 | MEDIDATA SOLUTIONS INC | 10,000 | 543,000 | 0.08% | ||
| 17 | SANGAMO THERAPEUTICS INCORPORATED | 50,000 | 555,000 | 0.08% | ||
| 18 | TETRAPHASE PHARMACEUTICALS INC COM | 12,000 | 569,000 | 0.08% | ||
| 19 | TESARO INCORPORATED | 10,300 | 606,000 | 0.08% | ||
| 20 | INNOVIVA INC COM | 35,000 | 632,000 | 0.09% | ||
| 21 | ABIOMED INC | 10,000 | 657,000 | 0.09% | ||
| 22 | PROTHENA CORP PLC | 13,000 | 685,000 | 0.10% | ||
| 23 | ENDOLOGIX INC | 50,000 | 767,000 | 0.11% | ||
| 24 | DYAX CORP COM CVR | 30,000 | 795,000 | 0.11% | ||
| 25 | ENDOCYTE INC | 158,000 | 820,000 | 0.11% | ||
| 26 | RESMED INC | 15,000 | 846,000 | 0.12% | ||
| 27 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 80,000 | 874,000 | 0.12% | ||
| 28 | NOVADAQ TECHNOLOGIES INC | 75,598 | 915,000 | 0.13% | ||
| 29 | ATHENA HEALTH INC. | 8,000 | 917,000 | 0.13% | ||
| 30 | IKANG HEALTHCARE GROUP INC | 50,000 | 967,000 | 0.13% | ||
| 31 | Juniper Pharmaceuticals Inc | 110,000 | 1,007,000 | 0.14% | ||
| 32 | XOMA CORP DEL | 295,000 | 1,145,000 | 0.16% | ||
| 33 | CENTENE CORP DEL | 15,000 | 1,206,000 | 0.17% | ||
| 34 | LABORATORY CORP AMER HLDGS | 10,000 | 1,212,000 | 0.17% | ||
| 35 | IMMUNOMEDICS INCORPORATED | 300,000 | 1,218,000 | 0.17% | ||
| 36 | MYRIAD GENETICS INC | 38,000 | 1,292,000 | 0.18% | ||
| 37 | Tekmira Pharmaceuticals Corp. | 125,000 | 1,483,000 | 0.21% | ||
| 38 | QIAGEN NV | 60,000 | 1,487,000 | 0.21% | ||
| 39 | IMPAX LABORATORIES INC | 32,600 | 1,497,000 | 0.21% | ||
| 40 | Heartware International, Inc. | 22,000 | 1,599,000 | 0.22% | ||
| 41 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,618,000 | 0.22% | ||
| 42 | DANAHER CORP DEL | 19,000 | 1,626,000 | 0.23% | ||
| 43 | INSULET CORPORATION | 52,500 | 1,627,000 | 0.23% | ||
| 44 | INOVIO PHARMACEUTICALS INC | 200,000 | 1,632,000 | 0.23% | ||
| 45 | ANGIODYNAMICS INC | 100,000 | 1,640,000 | 0.23% | ||
| 46 | LILLY ELI & CO | 20,000 | 1,670,000 | 0.23% | ||
| 47 | THERMO FISHER SCIENTIFIC INC | 13,000 | 1,687,000 | 0.23% | ||
| 48 | WELLCARE HEALTH PLANS INC | 20,000 | 1,697,000 | 0.24% | ||
| 49 | MANNKIND CORP. | 300,000 | 1,707,000 | 0.24% | ||
| 50 | INFINITY PHARMACEUTICALS INC | 164,000 | 1,796,000 | 0.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008658, filed 2015.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
